1. Home
  2. VSTM vs NCMI Comparison

VSTM vs NCMI Comparison

Compare VSTM & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • NCMI
  • Stock Information
  • Founded
  • VSTM 2010
  • NCMI 2005
  • Country
  • VSTM United States
  • NCMI United States
  • Employees
  • VSTM N/A
  • NCMI N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • NCMI Advertising
  • Sector
  • VSTM Health Care
  • NCMI Consumer Discretionary
  • Exchange
  • VSTM Nasdaq
  • NCMI Nasdaq
  • Market Cap
  • VSTM 425.9M
  • NCMI 476.2M
  • IPO Year
  • VSTM 2012
  • NCMI 2007
  • Fundamental
  • Price
  • VSTM $4.93
  • NCMI $5.18
  • Analyst Decision
  • VSTM Strong Buy
  • NCMI Strong Buy
  • Analyst Count
  • VSTM 8
  • NCMI 5
  • Target Price
  • VSTM $12.71
  • NCMI $7.60
  • AVG Volume (30 Days)
  • VSTM 2.6M
  • NCMI 676.0K
  • Earning Date
  • VSTM 08-07-2025
  • NCMI 08-04-2025
  • Dividend Yield
  • VSTM N/A
  • NCMI 1.16%
  • EPS Growth
  • VSTM N/A
  • NCMI N/A
  • EPS
  • VSTM N/A
  • NCMI N/A
  • Revenue
  • VSTM $10,000,000.00
  • NCMI $238,300,000.00
  • Revenue This Year
  • VSTM $129.06
  • NCMI $10.10
  • Revenue Next Year
  • VSTM $306.32
  • NCMI $11.66
  • P/E Ratio
  • VSTM N/A
  • NCMI N/A
  • Revenue Growth
  • VSTM N/A
  • NCMI 42.10
  • 52 Week Low
  • VSTM $2.10
  • NCMI $4.12
  • 52 Week High
  • VSTM $9.10
  • NCMI $7.60
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 30.80
  • NCMI 46.50
  • Support Level
  • VSTM $5.73
  • NCMI $5.15
  • Resistance Level
  • VSTM $6.62
  • NCMI $5.35
  • Average True Range (ATR)
  • VSTM 0.46
  • NCMI 0.21
  • MACD
  • VSTM -0.17
  • NCMI 0.02
  • Stochastic Oscillator
  • VSTM 0.84
  • NCMI 36.84

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: